Cargando…
IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation
N6-methyladenosine (m6A) is a common transcriptomic modification in cancer. Recently, it has been found to be involved in the regulation of non-small cell lung cancer (NSCLC) formation and metastasis. Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we...
Autores principales: | Mu, Xiaofeng, Zhao, Qi, Chen, Wen, Zhao, Yuxiang, Yan, Qing, Peng, Rui, Zhu, Jie, Yang, Chunrui, Lan, Ketao, Gu, Xiaosong, Wang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821743/ https://www.ncbi.nlm.nih.gov/pubmed/33489865 http://dx.doi.org/10.3389/fonc.2020.526866 |
Ejemplares similares
-
The role of IL-35 and IL-37 in breast cancer – potential therapeutic targets for precision medicine
por: Ma, Yuntao, et al.
Publicado: (2022) -
FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
por: Gan, Xiaojie, et al.
Publicado: (2022) -
Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease
por: Yin, Dan, et al.
Publicado: (2017) -
Exploration the Significance of a Novel Immune-Related Gene Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhao, Yajie, et al.
Publicado: (2020) -
Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process
por: Gu, Min, et al.
Publicado: (2023)